Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300067
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $20,826
Award facts
- Contract value 100% obligated
- $20,826.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
About this award
The federal contract award is for the procurement of "DRUGS AND BIOLOGICALS" by a U.S. government civilian agency, the Office of the Director. The $20,826.00 firm fixed price contract was awarded on July 11, 2014 to New England Biolabs, Inc., a for-profit manufacturer of molecular biology products based in Ipswich, Massachusetts. The contract has an ultimate completion date of December 31, 2014 and is a Blanket Purchase Agreement (BPA) call order, with no set-aside designation.
New England Biolabs is a leading supplier of reagents, kits, and enzymes for life sciences research, particularly within the National Institutes of Health (NIH) ecosystem. Under this contract, the company is providing a range of specialized biological materials used in genomics, infectious disease research, and other critical biomedical investigations, including next-generation sequencing technologies and molecular biology research supplies. The company has a significant $10,000,000 Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition Operations, effective from January 2024 to January 2026, which enables various NIH components to efficiently procure essential molecular biology products.
Quick answers
Who was awarded contract HHSN26300067?
HHSN26300067 was awarded to New England Biolabs, Inc. by Office of the Director (National Institutes of Health) on July 11, 2014.
How much is contract HHSN26300067 worth?
The government has obligated $20,826 on HHSN26300067.
Is contract HHSN26300067 an order under another contract?
Yes. HHSN26300067 is a BPA call under HHSN263201100018B, a blanket purchase agreement.
Was contract HHSN26300067 competed?
The extent of competition for HHSN26300067 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award